BOSTON SCIENTIFIC CORPORATION Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31)
BOSTON SCIENTIFIC CORPORATION (BSX) had Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) of $0 as of 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Notes
us-gaap:LineOfCreditFacilityAmountOutstanding · last filed 2012-11-06
- 2012-09-30: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
- 2012-06-30: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
- 2011-12-31: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $0.00.
- 2010-12-31: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $120.00M.
| Period end | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) as first filed |
|---|---|---|
| 2012-09-30 | $0.00 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-07 | |
| 2011-12-31 | $0.00 10-Q · filed 2012-11-06 | |
| 2010-12-31 | $120.00M 10-K · filed 2011-02-17 | |
| 2010-06-30 | $0.00 10-Q · filed 2010-08-05 | |
| 2010-01-31 | $250.00M 10-Q · filed 2011-08-05 | |
| 2009-12-31 | $123.00M 10-K · filed 2011-02-17 | $0.00 10-Q · filed 2010-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |